Author: "Fang, Zhaoyuan" / Database: Unpaywall - Searchworks@Jio Institute Digital Library Search Results

4. Multi-gradient Permutation Survival Analysis Identifies Mitosis and Immune Signatures Steadily Associated with Cancer Patient Prognosis

Author: Cai, Xinlei, primary, Ye, Yi, additional, Liu, Xiaoping, additional, Fang, Zhaoyuan, additional, Chen, Luonan, additional, Li, Fei, additional, and Ji, Hongbin, additional
Published: 2024
Full Text: View/download PDF

8. Simple-BEV: What Really Matters for Multi-Sensor BEV Perception?

Author: Harley, Adam W., primary, Fang, Zhaoyuan, additional, Li, Jie, additional, Ambrus, Rares, additional, and Fragkiadaki, Katerina, additional
Published: 2023
Full Text: View/download PDF

9. Figure S2 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

10. Figure S13 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

11. Data from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

12. Figure S5 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

13. Figure S7 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

14. Figure S4 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

15. Figure S9 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

16. Figure S6 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

17. Table S1 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

18. Data from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

19. Table S3 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

20. Figure S2 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

21. Figure S14 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

22. Figure S11 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

23. Figure S9 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

24. Figure S10 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

25. Figure S10 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

26. Figure S15 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

27. Figure S13 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

28. Figure S6 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

29. Figure S8 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

30. Figure S16 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

31. Figure S11 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

32. Figure S4 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

33. Figure S17 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

34. Figure S1 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

35. Figure S5 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

36. Figure S3 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

37. Figure S16 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

38. Figure S8 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

39. Figure S1 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

40. Table S2 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

41. Table S2 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

42. Figure S15 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

43. Figure S3 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

44. Table S3 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

45. Figure S17 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

46. Figure S12 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

47. Table S1 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

48. Figure S7 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

49. Figure S14 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

50. Figure S12 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Author: Li, Fei, primary, Huang, Qingyuan, primary, Luster, Troy A., primary, Hu, Hai, primary, Zhang, Hua, primary, Ng, Wai-Lung, primary, Khodadadi-Jamayran, Alireza, primary, Wang, Wei, primary, Chen, Ting, primary, Deng, Jiehui, primary, Ranieri, Michela, primary, Fang, Zhaoyuan, primary, Pyon, Val, primary, Dowling, Catríona M., primary, Bagdatlioglu, Ece, primary, Almonte, Christina, primary, Labbe, Kristen, primary, Silver, Heather, primary, Rabin, Alexandra R., primary, Jani, Kandarp, primary, Tsirigos, Aristotelis, primary, Papagiannakopoulos, Thales, primary, Hammerman, Peter S., primary, Velcheti, Vamsidhar, primary, Freeman, Gordon J., primary, Qi, Jun, primary, Miller, George, primary, and Wong, Kwok-Kin, primary
Published: 2023
Full Text: View/download PDF

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Publication Year Range

Publication Type

Journal

Database

Publisher

136 results on '"Fang, Zhaoyuan"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources